Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

444
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
444
Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings.

The Pediatric infectious disease journal·2026
Same author

Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2025.

Communicable diseases intelligence (2018)·2026
Same authorSame journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same authorSame journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same author

False-positive <i>Neisseria gonorrhoeae</i> results on the Abbott Alinity m STI assay caused by <i>Neisseria meningitidis</i>: two cases from Australia.

Journal of clinical microbiology·2026
Same author

Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022-2024.

Emerging infectious diseases·2026

Related Experiment Video

Updated: Jan 11, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K

Australian Meningococcal Surveillance Programme Annual Report, 2024.

Monica Lahra1, Siobhan Hurley2, C R Robert George3

  • 1NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au.

Communicable Diseases Intelligence (2018)
|November 17, 2025
PubMed
Summary
This summary is machine-generated.

Invasive meningococcal disease (IMD) notifications decreased by 5% in Australia in 2024. Serogroup B (MenB) predominated, particularly in children and young adults, with most isolates susceptible to key antibiotics.

Keywords:
Neisseria meningitidisantimicrobial resistancedisease surveillanceinvasive meningococcal disease

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.5K
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 11, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.5K
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.8K

Area of Science:

  • Epidemiology
  • Microbiology
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) is a significant public health concern in Australia.
  • Surveillance of IMD is crucial for understanding disease trends and guiding public health interventions.

Purpose of the Study:

  • To report on the epidemiology and laboratory characteristics of invasive meningococcal disease (IMD) cases in Australia for 2024.
  • To analyze serogroup distribution, antimicrobial susceptibility, and demographic patterns of IMD.

Main Methods:

  • Data collected through the National Notifiable Diseases Surveillance System (NNDSS).
  • Laboratory confirmation using bacterial culture and nucleic acid amplification testing.
  • Serogroup determination, porA finetyping, and antimicrobial susceptibility testing (AST) of isolates.

Main Results:

  • A 5% decrease in IMD notifications compared to 2023, with 136 cases reported.
  • Serogroup B (MenB) was the predominant serogroup (84%), followed by MenY (14%).
  • Highest incidence occurred in children under 5 years and young adults aged 15-24 years, with MenB dominating both groups. Penicillin resistance was observed in 7% of isolates, with intermediate susceptibility in 60%.

Conclusions:

  • Invasive meningococcal disease (IMD) remains a concern, with MenB being the primary driver.
  • Age-specific incidence highlights key populations for targeted surveillance and potential interventions.
  • While most isolates remain susceptible to ceftriaxone, ciprofloxacin, and rifampicin, evolving penicillin resistance patterns warrant continued monitoring.